A Novel Approach to Inhibit CD4 Exhaustion: Results of a Placebo-controlled Phase II Study of a gp41 Peptide Vaccine in HIV-1 Patients Under ART

AIDS RESEARCH AND HUMAN RETROVIRUSES(2018)

引用 0|浏览46
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要